HR Execs on the Move

Lycored

www.lycored.com

 
Nutrition isn`t complicated. For us, it`s natural. We`ve been a leader in the research and development of carotenoid-based products for the last two decades and we take that role very seriously. This means we approach everything we do with a sense of wonder and a driving desire to find the best possible outcome or create the highest-quality product.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.lycored.com
  • 33 Industrial Parkway
    Branchburg, NJ USA 08876
  • Phone: 877.592.6733

Executives

Name Title Contact Details
Shlomit Grouda
Senior Vice President of People Profile

Similar Companies

College Health Enterprises

College Health Enterprises is a Santa Fe Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SNBL Clinical Pharmacology Center

SNBL Clinical Pharmacology Center is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clean Plates

Clean Plates Omnimedia LLC is a premier media company focused on the new health and wellness food culture, with products that include digital, print and social media, as well as mobile apps. Begun in 2009 by Jared Koch–a certified nutritionist from the Institute for Integrative Nutrition and the Global Institute for Alternative Medicine—Clean Plates provides an integrative approach through food, sustainability, and wellness to optimize your health and happiness, thereby helping you perform at your peak—whether on the go, in the kitchen or dining out.

Diversified Portfolio Biotechnology

Diversified Portfolio Biotechnology is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Imagin Medical

Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.